Pharmaceutical Grade Ivabradine Hydrochloride CAS:148849-67-6 GMP Certified Supplier
Chemical Name:Ivabradine hydrochloride
CAS:148849-67-6
IUPAC Name:3-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-methylaminoethyl ester of (3R)-1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-([(1S)-1,4,6,7-tetrahydro-4-methyl-5H-indazol-5-yl]propyl)-1H-3-benzazepin-2-one hydrochloride
Molecular Formula:C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>5</sub>·HCl
Molecular Weight:505.05 g/mol
Appearance:White or almost white crystalline powder
Solubility:Freely soluble in water, methanol, and ethanol; slightly soluble in acetone
Melting Point:~195–197 °C (with decomposition)
pKa:~9.4 (basic)
Partition Coefficient (LogP):~2.7 (lipophilic)
Pharmacological Class:Selective If (funny current) channel inhibitor
Mechanism of Action:Reduces heart rate by inhibiting the pacemaker current (I<sub>f</sub>) in the sinoatrial node without affecting myocardial contractility or conduction
Therapeutic Uses:Treatment of chronic heart failure (HFrEF) and stable angina pectoris in patients with elevated heart rate
Protein Binding:~70%
Excretion Primarily via feces (≈70%) and urine (≈20%)
Brief Introduction
Ivabradine hydrochloride is a selective sinus node inhibitor that specifically blocks the I<sub>f</sub> current in cardiac pacemaker cells, reducing heart rate without negative inotropic effects. It is clinically used to manage chronic heart failure (especially HFrEF) and stable angina in patients with elevated resting heart rates who are intolerant to beta-blockers.